OBJECTIVE: To determine whether functional connectivity is altered in subjects with mutations in the microtubule associated protein tau (MAPT) gene who were asymptomatic but were destined to develop dementia, and to compare these findings to those in subjects with behavioral variant frontotemporal dementia (bvFTD). METHODS: In this case-control study, we identified 8 asymptomatic subjects with mutations in MAPT and 8 controls who screened negative for mutations in MAPT. Twenty-one subjects with a clinical diagnosis of bvFTD were also identified and matched to 21 controls. All subjects had resting-state fMRI. In-phase functional connectivity was assessed between a precuneus seed in the default mode network (DMN) and a fronto-insular cortex seed in the salience network, and the rest of the brain. Atlas-based parcellation was used to assess functional connectivity and gray matter volume across specific regions of interest. RESULTS: The asymptomatic MAPT subjects and subjects with bvFTD showed altered functional connectivity in the DMN, with reduced in-phase connectivity in lateral temporal lobes and medial prefrontal cortex, compared to controls. Increased in-phase connectivity was also observed in both groups in the medial parietal lobe. Only the bvFTD group showed altered functional connectivity in the salience network, with reduced connectivity in the fronto-insular cortex and anterior cingulate. Gray matter loss was observed across temporal, frontal, and parietal regions in bvFTD, but not in the asymptomatic MAPT subjects. CONCLUSIONS: Functional connectivity in the DMN is altered in MAPT subjects before the occurrence of both atrophy and clinical symptoms, suggesting that changes in functional connectivity are early features of the disease.
OBJECTIVE: To determine whether functional connectivity is altered in subjects with mutations in the microtubule associated protein tau (MAPT) gene who were asymptomatic but were destined to develop dementia, and to compare these findings to those in subjects with behavioral variant frontotemporal dementia (bvFTD). METHODS: In this case-control study, we identified 8 asymptomatic subjects with mutations in MAPT and 8 controls who screened negative for mutations in MAPT. Twenty-one subjects with a clinical diagnosis of bvFTD were also identified and matched to 21 controls. All subjects had resting-state fMRI. In-phase functional connectivity was assessed between a precuneus seed in the default mode network (DMN) and a fronto-insular cortex seed in the salience network, and the rest of the brain. Atlas-based parcellation was used to assess functional connectivity and gray matter volume across specific regions of interest. RESULTS: The asymptomatic MAPT subjects and subjects with bvFTD showed altered functional connectivity in the DMN, with reduced in-phase connectivity in lateral temporal lobes and medial prefrontal cortex, compared to controls. Increased in-phase connectivity was also observed in both groups in the medial parietal lobe. Only the bvFTD group showed altered functional connectivity in the salience network, with reduced connectivity in the fronto-insular cortex and anterior cingulate. Gray matter loss was observed across temporal, frontal, and parietal regions in bvFTD, but not in the asymptomatic MAPT subjects. CONCLUSIONS: Functional connectivity in the DMN is altered in MAPT subjects before the occurrence of both atrophy and clinical symptoms, suggesting that changes in functional connectivity are early features of the disease.
Authors: A Alberici; C Gobbo; A Panzacchi; F Nicosia; R Ghidoni; L Benussi; C Hock; A Papassotiropoulos; P Liberini; J H Growdon; G B Frisoni; A Villa; O Zanetti; S Cappa; F Fazio; G Binetti Journal: J Neurol Neurosurg Psychiatry Date: 2004-11 Impact factor: 10.154
Authors: Bharat B Biswal; Maarten Mennes; Xi-Nian Zuo; Suril Gohel; Clare Kelly; Steve M Smith; Christian F Beckmann; Jonathan S Adelstein; Randy L Buckner; Stan Colcombe; Anne-Marie Dogonowski; Monique Ernst; Damien Fair; Michelle Hampson; Matthew J Hoptman; James S Hyde; Vesa J Kiviniemi; Rolf Kötter; Shi-Jiang Li; Ching-Po Lin; Mark J Lowe; Clare Mackay; David J Madden; Kristoffer H Madsen; Daniel S Margulies; Helen S Mayberg; Katie McMahon; Christopher S Monk; Stewart H Mostofsky; Bonnie J Nagel; James J Pekar; Scott J Peltier; Steven E Petersen; Valentin Riedl; Serge A R B Rombouts; Bart Rypma; Bradley L Schlaggar; Sein Schmidt; Rachael D Seidler; Greg J Siegle; Christian Sorg; Gao-Jun Teng; Juha Veijola; Arno Villringer; Martin Walter; Lihong Wang; Xu-Chu Weng; Susan Whitfield-Gabrieli; Peter Williamson; Christian Windischberger; Yu-Feng Zang; Hong-Ying Zhang; F Xavier Castellanos; Michael P Milham Journal: Proc Natl Acad Sci U S A Date: 2010-02-22 Impact factor: 11.205
Authors: Zoe Arvanitakis; Robert J Witte; Dennis W Dickson; Yoshio Tsuboi; Ryan J Uitti; Jerzy Slowinski; Michael L Hutton; Siong-Chi Lin; Bradley F Boeve; William P Cheshire; Robert A Pooley; Julie M Liss; John N Caviness; Audrey J Strongosky; Zbigniew K Wszolek Journal: Parkinsonism Relat Disord Date: 2006-12-29 Impact factor: 4.891
Authors: J L Whitwell; C R Jack; J E Parisi; M L Senjem; D S Knopman; B F Boeve; R Rademakers; M Baker; R C Petersen; D W Dickson; K A Josephs Journal: Neurology Date: 2010-12-14 Impact factor: 9.910
Authors: Jennifer L Whitwell; Scott A Przybelski; Stephen D Weigand; Robert J Ivnik; Prashanthi Vemuri; Jeffrey L Gunter; Matthew L Senjem; Maria M Shiung; Bradley F Boeve; David S Knopman; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Keith A Josephs Journal: Brain Date: 2009-09-17 Impact factor: 13.501
Authors: Jonathan Beck; Jonathan D Rohrer; Tracy Campbell; Adrian Isaacs; Karen E Morrison; Emily F Goodall; Elizabeth K Warrington; John Stevens; Tamas Revesz; Janice Holton; Safa Al-Sarraj; Andrew King; Rachael Scahill; Jason D Warren; Nick C Fox; Martin N Rossor; John Collinge; Simon Mead Journal: Brain Date: 2008-01-29 Impact factor: 13.501
Authors: Gianina Toller; Jesse Brown; Marc Sollberger; Suzanne M Shdo; Laura Bouvet; Paul Sukhanov; William W Seeley; Bruce L Miller; Katherine P Rankin Journal: Cortex Date: 2018-02-27 Impact factor: 4.027
Authors: Elise G P Dopper; Serge A R B Rombouts; Lize C Jiskoot; Tom den Heijer; J Roos A de Graaf; Inge de Koning; Anke R Hammerschlag; Harro Seelaar; William W Seeley; Ilya M Veer; Mark A van Buchem; Patrizia Rizzu; John C van Swieten Journal: Neurology Date: 2013-02-06 Impact factor: 9.910
Authors: Baber K Khan; Jennifer S Yokoyama; Leonel T Takada; Sharon J Sha; Nicola J Rutherford; Jamie C Fong; Anna M Karydas; Teresa Wu; Robin S Ketelle; Matthew C Baker; Mariely-Dejesus Hernandez; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; Suzee E Lee; Howard J Rosen; Gil D Rabinovici; William W Seeley; Katherine P Rankin; Adam L Boxer; Bruce L Miller Journal: J Neurol Neurosurg Psychiatry Date: 2012-04 Impact factor: 10.154
Authors: Lucas Sedeño; Olivier Piguet; Sofía Abrevaya; Horacio Desmaras; Indira García-Cordero; Sandra Baez; Laura Alethia de la Fuente; Pablo Reyes; Sicong Tu; Sebastian Moguilner; Nicolas Lori; Ramon Landin-Romero; Diana Matallana; Andrea Slachevsky; Teresa Torralva; Dante Chialvo; Fiona Kumfor; Adolfo M García; Facundo Manes; John R Hodges; Agustin Ibanez Journal: Hum Brain Mapp Date: 2017-05-05 Impact factor: 5.038
Authors: Suzee E Lee; Anna M Khazenzon; Andrew J Trujillo; Christine C Guo; Jennifer S Yokoyama; Sharon J Sha; Leonel T Takada; Anna M Karydas; Nikolas R Block; Giovanni Coppola; Mochtar Pribadi; Daniel H Geschwind; Rosa Rademakers; Jamie C Fong; Michael W Weiner; Adam L Boxer; Joel H Kramer; Howard J Rosen; Bruce L Miller; William W Seeley Journal: Brain Date: 2014-10-01 Impact factor: 13.501